Rare diseases
Investigational molecules
Locations
Back to Germany349 clinical trials in Jena, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Dapagliflozin for Reducing Cardiovascular Events in Adults with High Blood Pressure
GermanyGermanyStudy of empagliflozin compared to placebo in patients with acute decompensated heart failure who are already taking SGLT2 inhibitors
GermanyStudy of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis
GermanyStudy of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
GermanyStudy of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer
GermanyStudy of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment
GermanyStudy of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies
GermanyStudy Comparing Golcadomide and Rituximab with Other Treatments for Patients with Relapsed or Refractory Follicular Lymphoma
GermanyStudy of NBTXR3 and Cetuximab for Elderly Patients with Advanced Head and Neck Cancer Ineligible for Platinum Chemotherapy
GermanyStudy of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Advanced or Recurrent Endometrial Cancer
GermanyStudy of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on multiple myeloma, prostate cancer, and gastric cancer treatments. Studies evaluating novel therapeutic combinations and targeted approaches for various cancer types.
Innovative treatments including antibody-drug conjugates and immunotherapy combinations for improved patient outcomes.
Research investigating treatments for hypertrophic cardiomyopathy and advanced cardiovascular disease. Trials exploring new approaches to reduce major cardiovascular events and improve patient quality of life.
Focus on both preventive measures and treatment of established cardiovascular conditions.
Clinical investigations of treatments for systemic lupus erythematosus, Sjögren's Disease, and other autoimmune conditions. Studies evaluating new biological therapies and targeted treatments.
Comprehensive research into improving treatment outcomes for patients with chronic autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
